Is concentric left ventricular (LV) remodeling the same as hypertrophy in a patient with a history of hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

No, Concentric LV Remodeling is NOT the Same as Hypertrophy

Concentric LV remodeling and concentric hypertrophy are distinct geometric patterns that differ fundamentally in left ventricular mass—remodeling has normal LV mass with increased wall thickness, while hypertrophy has increased LV mass with increased wall thickness. 1

Key Distinguishing Features

Concentric Remodeling

  • Normal LV mass: ≤115 g/m² (men) or ≤95 g/m² (women) 1
  • Increased relative wall thickness (RWT): ≥0.42 1
  • Normal or small LV cavity size with disproportionate wall thickening relative to chamber dimensions 2
  • Represents an earlier adaptive response to pressure overload where volume "underload" offsets the mass-increasing effects of pressure overload 3

Concentric Hypertrophy

  • Increased LV mass: >115 g/m² (men) or >95 g/m² (women) 1
  • Increased RWT: ≥0.42 1
  • Develops from chronic pressure overload with sarcomeres added in parallel, causing increased wall thickness 4
  • Represents true myocardial hypertrophy with increased total cardiac muscle mass 4

Clinical Significance: Why This Distinction Matters

Prognostic Implications

Both patterns carry adverse cardiovascular risk, but through different mechanisms:

  • Concentric remodeling independently predicts increased cardiovascular morbidity (relative risk 2.56) even with normal LV mass 5
  • This pattern shows more dramatic diastolic dysfunction degradation than other geometric patterns 2
  • Patients with concentric remodeling demonstrate reduced systolic function with lower stroke volume (84 vs 111 mL), lower midwall fractional shortening (20% vs 22%), and 42% classified below the 5th percentile for myocardial function despite normal LV mass 6

Hemodynamic Differences

  • Concentric remodeling: Highest peripheral resistance with low-normal cardiac index, reflecting pure pressure overload with volume underload 3
  • Concentric hypertrophy: Combined pressure overload with true hypertrophic response 3

Common Clinical Pitfall

Do not assume normal LV mass means normal cardiac function. The European Association of Cardiovascular Imaging and American Society of Echocardiography mandate that echocardiography reports describe LV geometry using all four categories: normal geometry, concentric remodeling, concentric hypertrophy, and eccentric hypertrophy 1. Missing the diagnosis of concentric remodeling because LV mass is "normal" leads to undertreatment of a high-risk geometric pattern.

Treatment Approach

Despite having normal LV mass, concentric remodeling requires aggressive treatment identical to that for concentric hypertrophy:

  • First-line: Angiotensin receptor blockers (ARBs), particularly losartan, or ACE inhibitors 2
  • Combination therapy: Consider aldosterone antagonists (eplerenone) or calcium channel blockers (verapamil/diltiazem) for persistent diastolic dysfunction 2
  • Target: Aggressive blood pressure control, as treatment-induced LV mass reduction (even from "normal" baseline) independently reduces cardiovascular events 2

The distinction between these patterns is not academic—concentric remodeling represents a maladaptive geometric response that predicts adverse outcomes despite normal LV mass 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Concentric LV Remodeling Treatment Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Concentric Hypertrophy vs Eccentric Hypertrophy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Systolic function in hypertensive men with concentric remodeling.

Hypertension (Dallas, Tex. : 1979), 1997

Related Questions

What does an echo finding of concentric remodeling and anterobasal septal hypertrophy indicate?
What is the primary treatment approach for a patient with concentric left ventricular (LV) remodeling and a history of hypertension?
What is the most appropriate initial antihypertensive medication for a patient with hypertension and left ventricular hypertrophy?
What is the approach to left ventricular hypertrophy (LVH)?
What is the primary risk factor for an elderly patient with ischemic heart disease (IHD), hypertension, and obesity, who is experiencing difficulty walking short distances and has mild left ventricular hypertrophy (LVH) on echocardiogram (echo)?
What is the best approach for managing cataracts in an older patient with comorbidities such as diabetes (Diabetes Mellitus), hypertension (Hypertension), and a history of smoking?
What is the most appropriate next step for a child with a recent upper respiratory tract infection (URTI) and a significant family history of cancer, including an uncle with leukemia and a brother with retinoblastoma?
What are the differential diagnoses and treatment options for a patient presenting with heel pain?
What is the management approach for an adult patient presenting with a phlebolith, considering their medical history of potential venous diseases such as deep vein thrombosis, varicose veins, or hemorrhoids?
What is the diagnosis and treatment for a patient presenting with gout-like symptoms but normal uric acid levels?
What is the best management approach for a patient with left ventricular (LV) remodeling and a history of hypertension (HTN) to reduce their risk of high cardiovascular disease (HCVD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.